Drug intelligence / Profile preview

chitosan + mineral trioxide aggregate

Development stage
Phase 2
Lead developer
Nourhan M. Aly
Modality
Small Molecules
Administration
Topical
01

Overview

This combination therapy consists of a 3D porous chitosan scaffold and Mineral Trioxide Aggregate (MTA), specifically the fast-setting EndoCem Zr formulation. It is designed for use as a pulpotomy agent in mature permanent teeth affected by irreversible pulpitis. Chitosan, a biocompatible and biodegradable polysaccharide derived from chitin, serves as a scaffold to support cellular attachment and tissue regeneration within the pulp chamber. MTA is a bioactive bioceramic material that releases calcium ions and creates an alkaline environment, promoting the formation of a mineralized dentinal bridge and providing a bacterial-tight seal. The combination aims to maintain tooth vitality and promote pulp healing as an alternative to conventional root canal treatment.

Brand names
EndoCem Zr
Other names
Chitosan scaffold/ MTA pulp dressing materialChitosan + MTAChitosan scaffold and Mineral trioxide aggregate
02

Targets

BMP2 (Bone morphogenetic protein 2)TGFB1 (Transforming growth factor Beta-1 proprotein)

Beyond the preview

Go deeper on chitosan + mineral trioxide aggregate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chitosan + mineral trioxide aggregate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call